Royalty Pharma (RPRX)
(Delayed Data from NSDQ)
$27.89 USD
+0.28 (1.01%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $27.89 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $0.96 | 5.21% |
Earnings Summary
For their last quarter, Royalty Pharma (RPRX) reported earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.03 per share. This reflects a positive earnings surprise of 11.65%. Look out for RPRX's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of $0.96 per share, reflecting a year-over-year decrease of 40%.
Earnings History
Price & Consensus
Zacks News for RPRX
Royalty Pharma (RPRX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
RPRX: What are Zacks experts saying now?
Zacks Private Portfolio Services